On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

Investigators conducted a systematic review and meta-analysis to elucidate the efficacy and safety of cTBS for the treatment of auditory hallucinations in schizophrenia.

Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...

The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

New drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.

Millions of Americans are affected by psychosis, a condition that includes schizophrenia, bipolar disorder, and depression.

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...